" class="no-js "lang="en-US"> Industry News Archives - Page 69 of 151 - Medtech Alert
Wednesday, October 08, 2025

Sort by:

Date

Top Post

ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients

ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]

Novasenta Completes $40 million Series A to Advance Novel Cancer Therapeutics

Novasenta Inc., a startup biotechnology company focused on the discovery and validation of novel targets […]

Pediatric Medical Centers Improve the Efficiency of Investigator-Initiated, Multi-Site, Collaborative Research with TriNetX

TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of […]

Vico Therapeutics Appoints Micah Mackison as Chief Executive Officer

Vico Therapeutics B.V., a neurology-focused genetic medicine company, today announced the appointment of Micah Mackison as Chief […]

Diagnostic Robotics Closes $45m Series B Funding Round

Diagnostic Robotics, a leading provider of Artificial Intelligence & Care Management solutions for Healthcare plans […]

PayGround Raises $5.5M in Latest Funding Round

PayGround, a healthcare fintech payments platform, today announced the completion of a $5.5M funding round led by FCA […]

Caption Health and Heartbeat Health Partner to Provide Unprecedented Access to Cardiac Care

Caption Health, the leader in providing services and AI to improve heart ultrasound access, and […]

Mymee Acquires Breakthrough Health, Leading Digital Health Platform for Multiple Sclerosis

Mymee, a leading provider of specialized care and support for people with significant symptoms associated […]

Velocity Clinical Research Begins European Expansion With German Site Acquisition

Velocity Clinical Research (“Velocity”), the leading integrated research site organisation, today announces it has acquired […]

Valo Therapeutics Acquires PeptiCHIP Technology Enabling Rapid Identification of Tumor Antigens for the Development of Personalized Immunotherapies

Valo Therapeutics Oy (ValoTx), the developer of novel, adaptable immunotherapy platforms for cancer and infectious […]

Calyx and Qynapse Partnering to Enable AI-enhanced Medical Imaging Services for CNS Clinical Trials

Calyx, the eClinical and Regulatory solutions and services provider relied on for solving complex data […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more